2020 Metastatic Breast Conference Speakers
*this information will be updated as more speakers are confirmed

Christine Hodgdon – Clinical Trials Panelist

Christine Hodgdon was a conservation biologist before her de novo triple positive metastatic breast cancer (MBC) diagnosis in 2015. She was fortunate enough to have a complete response to her treatments and with this “bonus” time, decided to leave her professional career to become a full time patient advocate. Christine has attended several scientific conferences, participated in advocacy trainings, and served as a research grant reviewer and helpline volunteer. Her passion, however, is increasing awareness and improving access to clinical trials for patients that have exhausted all of their treatment options and need help finding a trial for which they qualify. Frustrated with the inadequacies of the NCI clinical trial website, Christine created her own search algorithm to capture ALL possible trials for MBC patients and launched a website, TheStormRiders.org, which includes a searchable trial and drug database, a calendar of events, and research articles all specific to MBC patients.

Brenna Elliot, RN, BSN – Clinical Trials Panelist
*Bio forthcoming

Cheryl Erickson – Clinical Trials Panelist
*Bio forthcoming

Dr. Adam Brufsky – Bone Health Presentation

Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine’s Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women’s Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center. Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women’s Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.

Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army – Breast Cancer Research Program.

Dr. Daniel Hayes – Metastatic Cancer Research Presentation

Dr. Daniel Hayes is an authority in the field of breast cancer translational and clinical research and clinical care. His research focus is on the identification and validation of tumor biomarker tests. He received undergraduate, graduate (MS) and medical (MD) degrees from Indiana University, and completed a residency in Internal Medicine at the University of Texas Southwestern Medical School and a fellowship in medical oncology at Harvard’s Dana-Farber Cancer Institute, where he served on the faculty as Medical Director of the Breast Evaluation Center through 1996. Dr. Hayes then moved to Georgetown University as Director of the Breast Cancer Program of the Lombardi Cancer Center.

In 2001 he relocated to the University of Michigan. Dr. Hayes has published over 200 peer-reviewed publications, 24 clinical guidelines, and over 175 chapters, reviews, editorials and other educationally-related materials. He has directed translational investigations of several tumor marker tests for breast cancer, including tissue angiogenesis, estrogen receptor, and HER2 status, germline pharmacogenomics, and serum levels of CA15-3 (MUC-1 protein) and circulating tumor cells and tumor DNA. Dr. Hayes is currently Principle Investigator (PI) of a Susan G. Komen award. He chairs, or has chaired, several national and international scientific committees, including the Breast Cancer Translational Medicine subcommittee of SWOG, in which he mentored young investigators from other centers. He was the inaugural recipient of the American Society of Clinical Oncology (ASCO) Gianni Bonadonna Breast Cancer Award (2007), given for achievement in translational research and mentoring, and he has held many leadership roles in ASCO, including serving as President (2015-2018).

Dr. David Harris – Palliative Care Panelist

David Harris is a palliative medicine physician at The Cleveland Clinic. He finds meaning in his work when he is able to relieve the great suffering (physical, emotional, and sometimes spiritual) that comes with a cancer diagnosis.  In addition to seeing patients, David is a medical educator with a focus on teaching doctors-in-training how to communicate with patients, particularly when discussing bad news or having hard conversations. Outside of work David spends as much time as possible with his wonderful wife Julia and their pet dog, Goji. He enjoys reading and writing poetry and is trying (unsuccessfully) to learn how to garden.

Dr. Paul Hergenroeder – Palliative Care Panelist

Paul Hergenroeder MD is an Associate Medical Director of Hospice of Western Reserve (HWR). Since starting at HWR in June 2019, Dr. Hergenroeder has mostly assisted patients at the Ames Hospice House in Westlake.  From 2006 to 2019 Dr Paul was a medical oncologist at Metrohealth Medical Center with a focus on the treatment of breast cancer.  Dr. Hergenroeder is extremely grateful to the patients who have allowed him to be part of their care team in the spectrum of breast cancer risk, diagnosis, treatment, and post treatment goals of care.